PHASE III STUDY OF A NEW, LOW-DOSE LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM (LNG-IUS19.5MG) OVER 5 YEARS OF USE: EVALUATION OF BLEEDING AND DYSMENORRHEA.

被引：0
|
作者：
Faustmann, T. [1 ]
Nelson, A. [2 ]
Rosen, K. [3 ]
Schmelter, T. [1 ]
Apter, D. [4 ]
机构：
[1] Bayer Pharma AG, Berlin, Germany
[2] Los Angeles Biomed Res Inst, Los Angeles, CA USA
[3] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[4] Sexual Hlth Clin, Helsinki, Finland
来源：
FERTILITY AND STERILITY | 2015年 / 104卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2015.07.732
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-371
引用
收藏
页码：E232 / E232
页数：1
相关论文
共 21 条
  • [1] Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use
    Gemzell-Danielsson, Kristina
    Apter, Dan
    Dermout, Sylvia
    Faustmann, Thomas
    Rosen, Kimberly
    Schmelter, Thomas
    Merz, Martin
    Nelson, Anita
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 210 : 22 - 28
  • [2] A 12-MONTH, PHASE III STUDY OF A LOW-DOSE LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM (LNG-IUS13.5MG) IN POSTMENARCHEAL ADOLESCENTS: AN EVALUATION OF PLACEMENT EASE AND PAIN, BLEEDING AND DYSMENORRHEA
    Faustmann, T.
    Apter, D.
    Lukkari-Lax, E.
    Montegriffo, E.
    Gemzell-Danielsson, K.
    FERTILITY AND STERILITY, 2015, 104 (03) : E39 - E39
  • [3] A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg) in postmenarcheal adolescents
    Gemzell-Danielsson, Kristina
    Buhling, Kai J.
    Dermout, Sylvia M.
    Lukkari-Lax, Eeva
    Montegriffo, Elaine
    Apter, Dan
    CONTRACEPTION, 2016, 93 (06) : 507 - 512
  • [4] Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use (vol 210, pg 22, 2017)
    Gemzell-Danielsson, Kristina
    Apter, Dan
    Dermout, Sylvia
    Faustmann, Thomas
    Rosen, Kimberly
    Schmelter, Thomas
    Merz, Martin
    Nelson, Anita
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2019, 233 : 164 - 165
  • [5] HEALTH ECONOMIC EVIDENCE IN SUPPORT OF A LOW-DOSE CONTRACEPTIVE LEVONORGESTREL INTRAUTERINE SYSTEM (LNG-IUS 12)
    Trussell, J.
    Hassan, F.
    Henry, N.
    Law, A.
    Pocoski, J.
    Filonenko, A.
    VALUE IN HEALTH, 2012, 15 (07) : A539 - A539
  • [6] Evaluation of the Presence and Persistence of Ovarian Cysts in Users of a New Low-Dose Levonorgestrel-Releasing Intrauterine Contraceptive System over 5 Years
    Nahum, Gerard G.
    Kaunitz, Andrew M.
    Lukkari-Lax, Eeva
    Schmelter, Thomas
    Rosen, Kimberly
    JOURNAL OF REPRODUCTIVE MEDICINE, 2017, 62 (7-8) : 383 - 390
  • [7] EFFICACY AND SAFETY OF A LOW-DOSE LEVONORGESTREL INTRAUTERINE SYSTEM (LNG-IUS12) ACCORDING TO AGE, PARITY, AND BODY MASS INDEX OVER 5 YEARS OF USE.
    Faustmann, T. A.
    Gemzell-Danielsson, K.
    Apter, D.
    Rosen, K. A.
    Schmelter, T.
    Merz, M.
    Nelson, A.
    FERTILITY AND STERILITY, 2016, 106 (03) : E7 - E8
  • [8] Morphological and Ultrastructural Changes in Human Endometrium Following Low-Dose Levonorgestrel Contraceptive Intrauterine Systems (LNG-IUS-12) 13.5 mg
    Chai M.
    Su S.
    Dong B.
    The Journal of Obstetrics and Gynecology of India, 2015, 65 (5) : 323 - 327
  • [9] A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population
    Fan, Guangsheng
    Kang, Sukho
    Ren, Mulan
    Weisberg, Edith
    Lukkari-Lax, Eeva
    Roth, Katrin
    Shin, SoYoung
    CONTRACEPTION, 2017, 95 (04) : 371 - 377
  • [10] A MULTICENTER, RANDOMIZED, PHASE 3 STUDY OF TWO LOW-DOSE LEVONORGESTREL CONTRACEPTIVE INTRAUTERINE SYSTEMS (LNG-IUS): A SUBGROUP ANALYSIS IN NULLIPAROUS WOMEN
    Nelson, A. L.
    Gemzell-Danielsson, K.
    Drosman, S. R.
    Lynen, R.
    Rosen, K.
    FERTILITY AND STERILITY, 2012, 98 (03) : S196 - S196
123